The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 12th Mar 2014 09:03

Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation.Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral.British Land: Jefferies downgrades to hold with a target price of 707p.Brooks Macdonald Group: Canaccord Genuity increases target price from 1620p to 1780p, but downgrades from buy to hold.Brown (N) Group: UBS lowers target price from 565p to 535p and downgrades from neutral to sell.Cape: Canaccord Genuity ups target price from 300p to 360p maintaining a buy recommendation.Close Brothers Group: Berenberg raises target price from 1330p to 1640p and maintains a buy recommendation. JP Morgan increases target price from 1357p to 1480p and stays with its overweight rating. UBS raises target price from 1340p to 1420p maintaining a neutral rating.Countrywide: Goldman Sachs ups target price from 748p to 764p, while downgrading to neutral.Craneware: Investec raises target price from 615p to 645p keeping a buy recommendation.Crest Nicholson Holdings: Goldman Sachs shifts target price from 525p to 530p and upgrades to strong buy.esure Group: Deutsche Bank moves target price from 300p to 313p and keeps a buy recommendation. Citi shifts target price from 291p to 294p retaining a buy recommendation. Canaccord Genuity lowers target price from 305p to 295p maintaining its buy recommendation.Fenner: Jefferies lowers target price from 505p to 490p, while staying with its buy recommendation. Espirito Santo cuts target price from 410p to 400p and retains its neutral rating. UBS cuts target price from 500p to 480p leaving its buy recommendation unaltered.Go-Ahead Group: Deutsche Bank increases target price from 1640p to 2100p, while downgrading to hold. RBC Capital raises target price from 1800p to 2300p keeping its neutral rating.Hangar8: Westhouse Securities takes target price from 270p to 310p, but downgrades to add.Hikma Pharmaceuticals: Panmure Gordon ups target price from 1375p to 1400p, while downgrading from buy to hold.Hummingbird Resources: Cantor Fitzgerald moves target price from 68p to 80p leaving its buy recommendation unchanged.Hunting: Investec ups target price from 830p to 890p, but downgrades from buy to hold.IFG Group: N+1 Singer upgrades to buy with a target price of 150p.IMI: RBC Capital cuts target price from 1600p to 1550p and retains an outperform rating. Espirito Santo raises target price from 1530p to 1650p and upgrades to buy.Inchcape: Deutsche Bank ups target price from 655p to 685p and reiterates its hold recommendation. Nomura takes target price from 580p to 600p and maintains its neutral rating.Inmarsat: Jefferies moves target price from 790p to 800p and retains a buy recommendation.International Consolidated Airlines Group: Liberum Capital takes target price from 450p to 550p and keeps a buy recommendation.Kazakhmys: UBS raises target price from 210p to 300p and maintains a neutral rating.Land Securities: Jefferies downgrades to hold with a target price of 1112p.Merlin Entertainment: JP Morgan moves target price from 415p to 430p and maintains an overweight rating.Modern Water: Numis cuts target price from 77p to 62p, while its buy recommendation remains unchanged.Morgan Advanced Materials: Espirito Santo raises target price from 280p to 320p and retains a neutral rating.Persimmon: Goldman Sachs cuts target price from 1892p to 1840p and downgrades from strong buy to buy.Phoenix IT: Panmure Gordon lowers target price from 144p to 136p, while upgrading from hold to buy.Plethora Solutions: Daniel Stewart moves shifts target price from 18.9p to 25.6p and keeps a buy recommendation.Premier Farnell: UBS lowers target price from 240p to 235p and stays with its neutral rating.Redrow: Goldman Sachs raises target price from 341p to 423p upgrading to buy.Rentokil Initial: Credit Suisse ups target price from 95p to 125p and keeps a neutral rating.Rightmove: Goldman Sachs reduces target price from 4360p to 3607p and downgrades from strong buy to buy.Rockhopper Exploration: Canaccord Genuity reduces target price from 345p to 265p, but stays with its buy recommendation.Rotork: Espirito Santo increases target price from 2500p to 2600p and stays with its neutral rating.Servelec Group: Investec raises target price from 284p to 310p and maintains its buy recommendation.Spirax-Sarco Engineering: Espirito Santo raises target price from 3000p to 3200p and reiterates a neutral rating.Travis Perkins: Berenberg cuts target price from 1880p to 1800p and retains a hold recommendation.Tyman: Numis raises target price from 285p to 320p reiterating an add rating.WEIR Group: Espirito Santo raises target price from 2600p to 2800p and maintains a buy recommendation.
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.